Dashboard

Financial News

China property sales forecast cut by S&P as market slump deepens
hellenicshippingnews104d ago

China property sales forecast cut by S&P as market slump deepens

S&P Global Ratings has downgraded its forecast for China’s property sales in 2026, now predicting a 10% to 14% decline compared to its earlier October estimate of a 5% to 8% drop. “This is a downturn so entrenched that only the government has capacity to absorb the excess inventory,” S&P analysts wrote in a Sunday ...

#ECONOMY
Oil & Gas in 2026: The Next Chapter in the Energy Economy
hellenicshippingnews104d ago

Oil & Gas in 2026: The Next Chapter in the Energy Economy

Oil & gas companies are continuing to adjust from the meaningful swing in public policies between the prior U.S. presidential administration of President Biden and the second Trump administration, which entered office at the beginning of 2025. No longer beholden to a whole-of-government strategic goal to make the U.S. economy a net zero emitter by ...

#ECONOMY
Dow sets second straight record as tech rebound fuels Wall Street gains
staradvertiser104d ago

Dow sets second straight record as tech rebound fuels Wall Street gains

The S&P 500 and the Nasdaq rose solidly after a shaky start today, as technology stocks found their footing following last week’s AI-sparked selloff, while investors waited for key economic data that could shed light on the Federal Reserve’s interest-rate path.

#STOCKS#COMMODITIES
Why the Mag 7 Lost $950B in One Week
investorplace104d ago

Why the Mag 7 Lost $950B in One Week

InvestorPlace - Stock Market News, Stock Advice & Trading TipsLast week's tech chaos explained... why Alphabet and Amazon's spending shocked Wall Street... the Stage 1 to Stage 2 transition... which stocks face existential threat from AI... and how Louis and Luke are positioning for the winnersThe post Why the Mag 7 Lost $950B in One Week appeared first on InvestorPlace.

#STOCKS
Financial Analysis: Soleno Therapeutics (NASDAQ:SLNO) versus Surrozen (NASDAQ:SRZN)
themarketsdaily104d ago

Financial Analysis: Soleno Therapeutics (NASDAQ:SLNO) versus Surrozen (NASDAQ:SRZN)

Surrozen (NASDAQ:SRZN – Get Free Report) and Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation. Risk and Volatility Surrozen has a beta of 0.58, [...]

#STOCKS
Reviewing TreeHouse Foods (NYSE:THS) & SunOpta (NASDAQ:STKL)
thelincolnianonline104d ago

Reviewing TreeHouse Foods (NYSE:THS) & SunOpta (NASDAQ:STKL)

SunOpta (NASDAQ:STKL – Get Free Report) and TreeHouse Foods (NYSE:THS – Get Free Report) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Analyst Ratings This is a breakdown of [...]

#STOCKS
MFA Financial (NYSE:MFA) versus Altisource Portfolio Solutions (NASDAQ:ASPS) Head to Head Analysis
watchlistnews104d ago

MFA Financial (NYSE:MFA) versus Altisource Portfolio Solutions (NASDAQ:ASPS) Head to Head Analysis

Altisource Portfolio Solutions (NASDAQ:ASPS – Get Free Report) and MFA Financial (NYSE:MFA – Get Free Report) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk. Insider & Institutional Ownership 41.4% of [...]

#STOCKS
Portage Biotech (ATON) & The Competition Head-To-Head Review
tickerreport104d ago

Portage Biotech (ATON) & The Competition Head-To-Head Review

Portage Biotech (NASDAQ:ATON – Get Free Report) is one of 457 public companies in the “Pharmaceutical Preparations” industry, but how does it compare to its competitors? We will compare Portage Biotech to similar companies based on the strength of its dividends, risk, earnings, valuation, profitability, analyst recommendations and institutional ownership. Volatility and Risk Portage Biotech [...]

#STOCKS
Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) Head-To-Head Contrast
tickerreport104d ago

Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) Head-To-Head Contrast

Oncocyte (NASDAQ:IMDX – Get Free Report) and Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) are both manufacturing companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, risk, institutional ownership and earnings. Insider and Institutional Ownership 55.3% of Oncocyte shares are [...]

#STOCKS